Sun Pharma Advanced Research Company shareholding pattern

As of 07-2026, the promoter shareholding in Sun Pharma Advanced Research Company stands at 65.67% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Sun Pharma Advanced Research Company is 3.9% and 0% respectively.

The retail shareholding of the Sun Pharma Advanced Research Company is 30.34%.

Changes in shareholding patterns of Sun Pharma Advanced Research Company can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Sun Pharma Advanced Research Company are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.